Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, the third in a 3-part series on Ending the HIV Epidemic, Judith Feinberg, MD; and Kenneth Mayer, MD; discuss the important role of HIV pre-expsoure prophylaxis (PrEP) for preventing HIV infection among at-risk individuals and critical strategies for effective PrEP implementation among principle populations, including men who have sex with men and transgender women, heterosexual cisgender women, and people who inject drugs. Following their dialogue, the faculty field clinician questions on HIV prevention.
Judith Feinberg, MD
Departments of Medicine and Behavioral Medicine & Psychiatry
West Virginia University School of Medicine
Morgantown, West Virginia
Kenneth Mayer, MD
Infectious Disease Attending
Beth Israel Deaconess Medical Center
Professor of Medicine
Harvard Medical School
Medical Research Director
Fenway Community Health
Clinical Care Options (CCO) commentary by Dr Zhao Yan on data presented at CROI 2021 on the impact of the COVID-19 pandemic on HIV treatment
Clinical Care Options (CCO) commentary by Nelly Mugo, MD, on new data from Kenya on STI incidence and on PrEP uptake from CROI 2021
Download CCO slides reviewing clinically relevant new data reported at CROI 2021 on a wide range of ART management topics.
由专家选择的 2021 年 CROI 中的重要 HIV 数据，包括当前和研究性的 ART 疗法以及孕期和产后的 ART 疗法。数据由 CCO 提供